A2 Biotherapeutics Inc.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by A2 Biotherapeutics Inc.
RECRUITINGNCT04981119
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect...
Sponsor: A2 Biotherapeutics Inc.Enrolling: 20016 locations
Solid Tumor, AdultColorectal CancerNon Small Cell Lung Cancer+14
RECRUITINGPhase 1 / Phase 2NCT06051695
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid...
The goal of this study is to test autologous logic-gated Tmod™ CAR T-cell products in subjects with solid tumors including colorectal cancer (CRC), pancreatic cancer (PANC),...
Sponsor: A2 Biotherapeutics Inc.Enrolling: 47412 locations
Solid Tumor, AdultColorectal CancerNSCLC+17
RECRUITINGPhase 1 / Phase 2NCT06682793
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid...
The goal of this study is to test A2B395, an allogeneic logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorectal cancer (CRC), non-small cell lung...
Sponsor: A2 Biotherapeutics Inc.Enrolling: 24010 locations
Solid Tumor, AdultColorectal CancerNon-Small Cell Lung+14